{"data":[{"accessionNo":"0001193125-26-403411","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0000906709","issuerName":"NEKTAR THERAPEUTICS","ticker":"NKTR","cusip":"640268306","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-09-25","reportingPerson":"Sina Toussi","reportingCik":null,"personType":"IN,HC","sharesOwned":3345978,"percentOfClass":9.8,"filedAt":"2026-09-28","canonicalUrl":"https://xoomar.com/markets/stocks/nktr"},{"accessionNo":"0001193125-26-403411","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0000906709","issuerName":"NEKTAR THERAPEUTICS","ticker":"NKTR","cusip":"640268306","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-09-25","reportingPerson":"Two Seas Capital GP LLC","reportingCik":null,"personType":"OO,HC","sharesOwned":3345978,"percentOfClass":9.8,"filedAt":"2026-09-28","canonicalUrl":"https://xoomar.com/markets/stocks/nktr"},{"accessionNo":"0001193125-26-403411","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0000906709","issuerName":"NEKTAR THERAPEUTICS","ticker":"NKTR","cusip":"640268306","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-09-25","reportingPerson":"Two Seas Capital LP","reportingCik":null,"personType":"IA,PN","sharesOwned":3345978,"percentOfClass":9.8,"filedAt":"2026-09-28","canonicalUrl":"https://xoomar.com/markets/stocks/nktr"},{"accessionNo":"0001011438-26-000548","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000906709","issuerName":"NEKTAR THERAPEUTICS","ticker":"NKTR","cusip":"640268306","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-06-30","reportingPerson":"Sina Toussi","reportingCik":null,"personType":"IN,HC","sharesOwned":3092234,"percentOfClass":9.1,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/nktr"},{"accessionNo":"0001011438-26-000548","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000906709","issuerName":"NEKTAR THERAPEUTICS","ticker":"NKTR","cusip":"640268306","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-06-30","reportingPerson":"Two Seas Capital LP","reportingCik":null,"personType":"IA,PN","sharesOwned":3092234,"percentOfClass":9.1,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/nktr"},{"accessionNo":"0001011438-26-000548","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000906709","issuerName":"NEKTAR THERAPEUTICS","ticker":"NKTR","cusip":"640268306","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-06-30","reportingPerson":"Two Seas Capital GP LLC","reportingCik":null,"personType":"OO,HC","sharesOwned":3092234,"percentOfClass":9.1,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/nktr"},{"accessionNo":"0000921895-26-002174","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0000906709","issuerName":"NEKTAR THERAPEUTICS","ticker":"NKTR","cusip":"640268306","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-06-30","reportingPerson":"LAMPERT MARK N","reportingCik":null,"personType":"IN","sharesOwned":2391075,"percentOfClass":7.1,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/nktr"},{"accessionNo":"0000921895-26-002174","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0000906709","issuerName":"NEKTAR THERAPEUTICS","ticker":"NKTR","cusip":"640268306","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-06-30","reportingPerson":"BVF PARTNERS L P/IL","reportingCik":null,"personType":"IA,PN","sharesOwned":2391075,"percentOfClass":7.1,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/nktr"},{"accessionNo":"0000921895-26-002174","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0000906709","issuerName":"NEKTAR THERAPEUTICS","ticker":"NKTR","cusip":"640268306","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-06-30","reportingPerson":"BVF INC/IL","reportingCik":null,"personType":"CO","sharesOwned":2391075,"percentOfClass":7.1,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/nktr"},{"accessionNo":"0000921895-26-002174","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0000906709","issuerName":"NEKTAR THERAPEUTICS","ticker":"NKTR","cusip":"640268306","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-06-30","reportingPerson":"BVF GP HOLDINGS LLC","reportingCik":null,"personType":"OO","sharesOwned":2197386,"percentOfClass":6.5,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/nktr"},{"accessionNo":"0000921895-26-002174","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0000906709","issuerName":"NEKTAR THERAPEUTICS","ticker":"NKTR","cusip":"640268306","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-06-30","reportingPerson":"BVF I GP LLC","reportingCik":null,"personType":"OO","sharesOwned":1251654,"percentOfClass":3.7,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/nktr"},{"accessionNo":"0000921895-26-002174","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0000906709","issuerName":"NEKTAR THERAPEUTICS","ticker":"NKTR","cusip":"640268306","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-06-30","reportingPerson":"BIOTECHNOLOGY VALUE FUND L P","reportingCik":null,"personType":"PN","sharesOwned":1251654,"percentOfClass":3.7,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/nktr"},{"accessionNo":"0000921895-26-002174","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0000906709","issuerName":"NEKTAR THERAPEUTICS","ticker":"NKTR","cusip":"640268306","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-06-30","reportingPerson":"BIOTECHNOLOGY VALUE FUND II LP","reportingCik":null,"personType":"PN","sharesOwned":945732,"percentOfClass":2.8,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/nktr"},{"accessionNo":"0000921895-26-002174","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0000906709","issuerName":"NEKTAR THERAPEUTICS","ticker":"NKTR","cusip":"640268306","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-06-30","reportingPerson":"BVF II GP LLC","reportingCik":null,"personType":"OO","sharesOwned":945732,"percentOfClass":2.8,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/nktr"},{"accessionNo":"0000921895-26-002174","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0000906709","issuerName":"NEKTAR THERAPEUTICS","ticker":"NKTR","cusip":"640268306","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-06-30","reportingPerson":"Biotechnology Value Trading Fund OS LP","reportingCik":null,"personType":"PN","sharesOwned":157488,"percentOfClass":0.5,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/nktr"},{"accessionNo":"0000921895-26-002174","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0000906709","issuerName":"NEKTAR THERAPEUTICS","ticker":"NKTR","cusip":"640268306","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-06-30","reportingPerson":"BVF Partners OS Ltd.","reportingCik":null,"personType":"CO","sharesOwned":157488,"percentOfClass":0.5,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/nktr"},{"accessionNo":"0002100119-26-001473","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000906709","issuerName":"Nektar Therapeutics","ticker":"NKTR","cusip":"640268306","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"Vanguard Capital Management","reportingCik":null,"personType":"IA","sharesOwned":1747653,"percentOfClass":5.17,"filedAt":"2026-07-31","canonicalUrl":"https://xoomar.com/markets/stocks/nktr"},{"accessionNo":"0002012383-26-002912","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000906709","issuerName":"NEKTAR THERAPEUTICS","ticker":"NKTR","cusip":"640268306","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":2643796,"percentOfClass":7.8,"filedAt":"2026-07-29","canonicalUrl":"https://xoomar.com/markets/stocks/nktr"},{"accessionNo":"0000921895-26-001397","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000906709","issuerName":"NEKTAR THERAPEUTICS","ticker":"NKTR","cusip":"640268306","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-03-31","reportingPerson":"BVF INC/IL","reportingCik":null,"personType":"CO","sharesOwned":2852698,"percentOfClass":9.8,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/nktr"},{"accessionNo":"0000921895-26-001397","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000906709","issuerName":"NEKTAR THERAPEUTICS","ticker":"NKTR","cusip":"640268306","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-03-31","reportingPerson":"LAMPERT MARK N","reportingCik":null,"personType":"IN","sharesOwned":2852698,"percentOfClass":9.8,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/nktr"},{"accessionNo":"0000921895-26-001397","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000906709","issuerName":"NEKTAR THERAPEUTICS","ticker":"NKTR","cusip":"640268306","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-03-31","reportingPerson":"BVF PARTNERS L P/IL","reportingCik":null,"personType":"IA,PN","sharesOwned":2852698,"percentOfClass":9.8,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/nktr"},{"accessionNo":"0000921895-26-001397","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000906709","issuerName":"NEKTAR THERAPEUTICS","ticker":"NKTR","cusip":"640268306","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-03-31","reportingPerson":"BVF GP HOLDINGS LLC","reportingCik":null,"personType":"OO","sharesOwned":2638052,"percentOfClass":9.1,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/nktr"},{"accessionNo":"0000921895-26-001397","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000906709","issuerName":"NEKTAR THERAPEUTICS","ticker":"NKTR","cusip":"640268306","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-03-31","reportingPerson":"BIOTECHNOLOGY VALUE FUND L P","reportingCik":null,"personType":"PN","sharesOwned":1523980,"percentOfClass":5.3,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/nktr"},{"accessionNo":"0000921895-26-001397","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000906709","issuerName":"NEKTAR THERAPEUTICS","ticker":"NKTR","cusip":"640268306","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-03-31","reportingPerson":"BVF I GP LLC","reportingCik":null,"personType":"OO","sharesOwned":1523980,"percentOfClass":5.3,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/nktr"},{"accessionNo":"0000921895-26-001397","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000906709","issuerName":"NEKTAR THERAPEUTICS","ticker":"NKTR","cusip":"640268306","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-03-31","reportingPerson":"BIOTECHNOLOGY VALUE FUND II LP","reportingCik":null,"personType":"PN","sharesOwned":1114072,"percentOfClass":3.9,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/nktr"},{"accessionNo":"0000921895-26-001397","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000906709","issuerName":"NEKTAR THERAPEUTICS","ticker":"NKTR","cusip":"640268306","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-03-31","reportingPerson":"BVF II GP LLC","reportingCik":null,"personType":"OO","sharesOwned":1114072,"percentOfClass":3.9,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/nktr"},{"accessionNo":"0000921895-26-001397","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000906709","issuerName":"NEKTAR THERAPEUTICS","ticker":"NKTR","cusip":"640268306","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-03-31","reportingPerson":"Biotechnology Value Trading Fund OS LP","reportingCik":null,"personType":"PN","sharesOwned":171769,"percentOfClass":0.6,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/nktr"},{"accessionNo":"0000921895-26-001397","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000906709","issuerName":"NEKTAR THERAPEUTICS","ticker":"NKTR","cusip":"640268306","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-03-31","reportingPerson":"BVF Partners OS Ltd.","reportingCik":null,"personType":"CO","sharesOwned":171769,"percentOfClass":0.6,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/nktr"},{"accessionNo":"0000315066-26-001260","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000906709","issuerName":"NEKTAR THERAPEUTICS","ticker":"NKTR","cusip":"640268306","securityClass":"COMMON STOCK","eventDate":"2026-03-31","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":4303188.37,"percentOfClass":15,"filedAt":"2026-05-06","canonicalUrl":"https://xoomar.com/markets/stocks/nktr"},{"accessionNo":"0000315066-26-001260","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000906709","issuerName":"NEKTAR THERAPEUTICS","ticker":"NKTR","cusip":"640268306","securityClass":"COMMON STOCK","eventDate":"2026-03-31","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":4303188.37,"percentOfClass":15,"filedAt":"2026-05-06","canonicalUrl":"https://xoomar.com/markets/stocks/nktr"},{"accessionNo":"0001011438-26-000242","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000906709","issuerName":"NEKTAR THERAPEUTICS","ticker":"NKTR","cusip":"640268306","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-03-31","reportingPerson":"Two Seas Capital LP","reportingCik":null,"personType":"IA,PN","sharesOwned":1959178,"percentOfClass":6.8,"filedAt":"2026-04-17","canonicalUrl":"https://xoomar.com/markets/stocks/nktr"},{"accessionNo":"0001011438-26-000242","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000906709","issuerName":"NEKTAR THERAPEUTICS","ticker":"NKTR","cusip":"640268306","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-03-31","reportingPerson":"Two Seas Capital GP LLC","reportingCik":null,"personType":"OO,HC","sharesOwned":1959178,"percentOfClass":6.8,"filedAt":"2026-04-17","canonicalUrl":"https://xoomar.com/markets/stocks/nktr"},{"accessionNo":"0001011438-26-000242","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000906709","issuerName":"NEKTAR THERAPEUTICS","ticker":"NKTR","cusip":"640268306","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-03-31","reportingPerson":"Sina Toussi","reportingCik":null,"personType":"IN,HC","sharesOwned":1959178,"percentOfClass":6.8,"filedAt":"2026-04-17","canonicalUrl":"https://xoomar.com/markets/stocks/nktr"},{"accessionNo":"0000102909-26-001820","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000906709","issuerName":"Nektar Therapeutics","ticker":"NKTR","cusip":"640268306","securityClass":"Common Stock","eventDate":"2026-03-13","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-03-27","canonicalUrl":"https://xoomar.com/markets/stocks/nktr"},{"accessionNo":"0000315066-26-000649","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000906709","issuerName":"NEKTAR THERAPEUTICS","ticker":"NKTR","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2026-02-27","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":3036760.61,"percentOfClass":11.1,"filedAt":"2026-03-06","canonicalUrl":"https://xoomar.com/markets/stocks/nktr"},{"accessionNo":"0000315066-26-000649","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000906709","issuerName":"NEKTAR THERAPEUTICS","ticker":"NKTR","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2026-02-27","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":3036760.61,"percentOfClass":11.1,"filedAt":"2026-03-06","canonicalUrl":"https://xoomar.com/markets/stocks/nktr"},{"accessionNo":"0001446580-26-000040","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000906709","issuerName":"Nektar Therapeutics","ticker":"NKTR","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"G1 Execution Services, LLC","reportingCik":null,"personType":"BD,OO","sharesOwned":809967,"percentOfClass":4,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/nktr"},{"accessionNo":"0001446580-26-000040","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000906709","issuerName":"Nektar Therapeutics","ticker":"NKTR","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"Susquehanna Portfolio Strategies, LLC","reportingCik":null,"personType":"OO","sharesOwned":809967,"percentOfClass":4,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/nktr"},{"accessionNo":"0001446580-26-000040","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000906709","issuerName":"Nektar Therapeutics","ticker":"NKTR","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"Susquehanna Securities, LLC","reportingCik":null,"personType":"BD,OO","sharesOwned":809967,"percentOfClass":4,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/nktr"},{"accessionNo":"0000102909-26-000212","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000906709","issuerName":"Nektar Therapeutics","ticker":"NKTR","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":1027089,"percentOfClass":5.04,"filedAt":"2026-01-30","canonicalUrl":"https://xoomar.com/markets/stocks/nktr"},{"accessionNo":"0001104659-25-112619","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000906709","issuerName":"NEKTAR THERAPEUTICS","ticker":"NKTR","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2025-09-30","reportingPerson":"Nantahala Capital Management, LLC","reportingCik":null,"personType":"IA","sharesOwned":418522,"percentOfClass":2.2,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/nktr"},{"accessionNo":"0001104659-25-112619","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000906709","issuerName":"NEKTAR THERAPEUTICS","ticker":"NKTR","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2025-09-30","reportingPerson":"Wilmot B. Harkey","reportingCik":null,"personType":"HC","sharesOwned":418522,"percentOfClass":2.2,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/nktr"},{"accessionNo":"0001104659-25-112619","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000906709","issuerName":"NEKTAR THERAPEUTICS","ticker":"NKTR","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2025-09-30","reportingPerson":"Daniel Mack","reportingCik":null,"personType":"HC","sharesOwned":418522,"percentOfClass":2.2,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/nktr"},{"accessionNo":"0001193125-25-283066","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0000906709","issuerName":"Nektar Therapeutics, Inc.","ticker":"NKTR","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"TCG Crossover GP II, LLC","reportingCik":null,"personType":"OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/nktr"},{"accessionNo":"0001193125-25-283066","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0000906709","issuerName":"Nektar Therapeutics, Inc.","ticker":"NKTR","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"TCG Crossover Fund II, L.P.","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/nktr"},{"accessionNo":"0001193125-25-283066","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0000906709","issuerName":"Nektar Therapeutics, Inc.","ticker":"NKTR","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Chen Yu","reportingCik":null,"personType":"IN","sharesOwned":0,"percentOfClass":0,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/nktr"},{"accessionNo":"0001446580-25-000123","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000906709","issuerName":"Nektar Therapeutics","ticker":"NKTR","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-09-30","reportingPerson":"Susquehanna Securities, LLC","reportingCik":null,"personType":"BD,OO","sharesOwned":1235864,"percentOfClass":6.3,"filedAt":"2025-11-13","canonicalUrl":"https://xoomar.com/markets/stocks/nktr"},{"accessionNo":"0001446580-25-000123","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000906709","issuerName":"Nektar Therapeutics","ticker":"NKTR","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-09-30","reportingPerson":"Susquehanna Portfolio Strategies, LLC","reportingCik":null,"personType":"OO","sharesOwned":1235864,"percentOfClass":6.3,"filedAt":"2025-11-13","canonicalUrl":"https://xoomar.com/markets/stocks/nktr"},{"accessionNo":"0000102909-25-000266","formType":"SCHEDULE 13G/A","amendmentNo":14,"issuerCik":"0000906709","issuerName":"Nektar Therapeutics","ticker":"NKTR","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":948647,"percentOfClass":4.98,"filedAt":"2025-10-31","canonicalUrl":"https://xoomar.com/markets/stocks/nktr"},{"accessionNo":"0001104659-25-103174","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000906709","issuerName":"Nektar Therapeutics","ticker":"NKTR","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Israel A. Englander","reportingCik":null,"personType":"IN","sharesOwned":570994,"percentOfClass":3,"filedAt":"2025-10-28","canonicalUrl":"https://xoomar.com/markets/stocks/nktr"},{"accessionNo":"0001104659-25-103174","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000906709","issuerName":"Nektar Therapeutics","ticker":"NKTR","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Millennium Management LLC","reportingCik":null,"personType":"OO","sharesOwned":570994,"percentOfClass":3,"filedAt":"2025-10-28","canonicalUrl":"https://xoomar.com/markets/stocks/nktr"},{"accessionNo":"0001104659-25-103174","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000906709","issuerName":"Nektar Therapeutics","ticker":"NKTR","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Millennium Group Management LLC","reportingCik":null,"personType":"OO","sharesOwned":570994,"percentOfClass":3,"filedAt":"2025-10-28","canonicalUrl":"https://xoomar.com/markets/stocks/nktr"},{"accessionNo":"0001104659-25-103174","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000906709","issuerName":"Nektar Therapeutics","ticker":"NKTR","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Integrated Core Strategies (US) LLC","reportingCik":null,"personType":"OO","sharesOwned":333576,"percentOfClass":1.8,"filedAt":"2025-10-28","canonicalUrl":"https://xoomar.com/markets/stocks/nktr"}],"updatedAt":"2026-11-05T15:20:56.531Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/nktr","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}